Uniphar, a global leader in pharmaceutical and medtech solutions has announced the launch of its 10th cell and gene therapy ...

GSK’s five-in-one meningococcal vaccine has been recommended by the US Centers for Disease Control and Prevention’s (CDC) ...

LEO Pharma and the Parker Institute at Copenhagen University Hospital have entered into a three-year academic partnership aimed at advancing dermatology research. The alliance will focus on enhancing ...

The US Food and Drug Administration (FDA) has designated Celltrion’s Yuflyma (adalimumab-aaty) as an interchangeable biosimilar to AbbVie’s Humira (adalimumab). The decision allows Yuflyma to be ...

Ageing is associated with significant immunological changes that can influence both the progression of the disease and the ...

Rapidly growing pharmaceutical services platform unveils new integrated structure for global evidence solutions.

This shift is transforming the dynamic between patients and healthcare professionals (HCPs) and in turn, the decision-making ...

Biogen and Eisai’s Alzheimer’s disease (AD) drug Leqembi (lecanemab) has been approved by the European Commission (EC). The ...

Merck & Co – known as MSD outside of the US and Canada – and Cyprumed have entered into a partnership aimed at developing ...

Boehringer Ingelheim and Cue Biopharma have announced a partnership worth $357m to develop and commercialise Cue’s ...

Exclusion from healthcare decisions can result from various barriers, including language, health literacy, cultural factors ...

FRONTERA GROUP is a cross-functional blend of behaviour and creative engagement experts. Our approach identifies the underlying drivers of decision making, to uncover how choices are made today and ...